Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used during pregnancy. Findings that prenatal NSAID exposure may affect offspring neurodevelopment have been inconsistent. We investigated the effect of prenatal NSAID exposure on childhood neurodevelopment and explored the susceptibility of our effect estimates to forms of bias via negative exposure, negative outcome, and multi-informant analyses.
| INTRODUCTION
Medication use during pregnancy is common. 1 One of the most frequently prescribed medications during pregnancy is non-steroidal anti-inflammatory drugs (NSAIDs). [2] [3] [4] [5] [6] Over-the-counter use of NSAIDs is widespread, especially during the first trimester of pregnancy. 7, 8 As medication use during pregnancy may pose a risk to the mother and her developing fetus, the potential benefits of the medication must be weighed against the risks for both mother and child. Therefore, information to guide patients and physicians to make a well-informed decision for the appropriate treatment during pregnancy is needed.
NSAIDs, for example ibuprofen, naproxen, diclofenac, and aspirin (acetylsalicylic acid), 9 are widely recognized for their analgesic, antipyretic, and anti-inflammatory effects. 10 The action of NSAIDs results from cyclooxygenase (COX) inhibition, followed by suppression of prostaglandin synthesis in the brain. 11 Based on animal studies, COX-2 has been shown to be present in the brain and seems to play an essential role in neurodevelopment. 12, 13 Thus, a key question is whether prenatal NSAID use has effects on foetal brain development.
Earlier research examining the association between prenatal exposure to NSAIDs and cognitive impairment in children has been inconsistent, with studies finding negative 14 and positive 15 associations with intelligence measures and cognitive functioning. For behavioral outcomes such as Attention Deficit Hyperactivity Disorder and attention problems, results have likewise been inconsistent. One animal study reported a protective effect on the risk of behavioral difficulties and hyperactivity. 16 In epidemiologic studies, some studies have found no association 17 while others have reported higher risks of attention problems among children exposed to NSAIDs in utero.
14 Discrepancies in previous research may be explained by: small sample sizes; differences in study populations (eg, one study restricted to children born preterm 17 ); and differing susceptibilities to biases such as residual confounding by indication, 18 and artifacts of the study design (eg, retrospective versus prospective 14 studies), or available measures for medication use (eg, self-report versus prescription) or outcome (eg, parent report versus other informants). In the absence of randomized trials, a crucial challenge faced by all these studies is disentangling the neurodevelopmental consequences of prenatal NSAIDs exposure from the effects of the underlying indication for drug use (ie, confounding by indication). 19 Unlike more specialized prescription drugs with well-defined indications for use, analgesics are used for a wide range of indications. 18 Hence, confounders can be especially difficult to define, measure, and appropriately adjust for.
The aim of the current study is to investigate the effect of prenatal exposure to NSAIDs and neurodevelopment of children. We begin by estimating effects on neurodevelopmental outcomes while adjusting for many sources of potential confounding. To explore possible systematic biases to our estimates and prior studies' estimates, we compared our estimates from maternally reported outcomes to a teacher's report and further used NSAID use before pregnancy and somatic problems as a "negative" exposure and outcome, respectively. 20 2 | METHODS
| Study design and participants
This study was embedded in the Generation R Study, a populationbased prospective cohort from foetal life onwards. 21, 22 Briefly, all 
| Measurements

| Prenatal NSAID exposure
NSAID use during pregnancy was assessed via both self-report and prescription records. In each trimester, pregnant mothers reported in questionnaires whether they had used any medication. In the first trimester, the mothers were asked whether they used medications within the past 6 months. The mothers filled out the type of medication and when it was used (during pregnancy, only before pregnancy, or stopped when I knew I was pregnant). In the second and third trimesters, we asked which medications were used in the preceding 3 months. From these questionnaires, we assessed NSAIDs exposure and timing (before or during pregnancy). One question with several open text fields was used, and thus information was not systematically collected. Further, no additional methods were used to enhance medication recall during pregnancy.
We asked women for permission to contact their pharmacy to obtain information on filled prescriptions. For the large majority, permission was obtained, and data were requested, but prescription records were only available in 60.2% (n = 4142) of our study sample
KEY POINTS
• Little is known about the effect of prenatal exposure to non-steroidal anti-inflammatory drugs (NSAIDs) on child development.
• It is important to address sources of potential confounding in pharmacoepidemiologic studies that investigate prenatal drug exposure and subsequent child development.
• This study investigated sources of confounding by controlling for several potential confounders, using outcomes measured repeatedly and across different informants, studying pre-pregnancy exposure, and using proposed negative outcomes.
• The association of prenatal exposure to NSAIDs and child attention problems is possibly partly explained by residual confounding by indication and measurementrelated biases.
• Future studies may consider using more objective measurements of outcomes alongside richer assessments of women's decisions to use NSAIDs prior to and during pregnancy.
due to a delay in linkage (this specific data collection started later and could not be retrieved in all participants). 
| Behavioral and emotional problems
At the age of 1½, 3, and 5 year, child problem behaviour was assessed using the Dutch version of the Child Behavior Checklist for ages 1½ to 5 years (CBCL/1½-5). 24 The CBCL/1½-5 is a 99-item parent report on problem behaviors with well-established psychometric properties. 25 The Dutch version of the CBCL/1½ -5 is reliable and well validated, 26 and the subscales had a good fit in 23 international studies across diverse societies. 27 The current study focused on the CBCL subscales for attention problems and somatic complaints. The CBCL has good reliability and validity; the internal consistency of the attention problems and somatic complaints scale, measured by Cronbach's alpha was 0.68 and 0.80. 24 Attention problems were also rated by teachers using the Teacher's Report Form 25 when the children were aged 6 years.
Although 40% of children were 6 years or older at the time of assessment, we used the CBCL 1.5-5 (preschool version) for reasons of continuity.
| Nonverbal intelligence
We used the Snijders-Oomen Non-verbal Intelligence Test 2.5-7-Revised (SON-R 2.5-7), 28 a reliable and valid measure. [28] [29] [30] Two subtests of the SON-R 2.5-7 were administered in Generation R at age 6 years: Mosaics, assessing spatial visualization abilities, and Categories, assessing abstract reasoning abilities. A scaled total score can be calculated for any combination of subtests with the same distribution characteristics as the IQ score. A correlation of r = 0.86 was found between the score derived from the Mosaics and Categories subsets, and the IQ scores derived from the complete test. 28 The raw scores of each subtest were standardized; the sum of the standardized scores were converted into SON-R IQ score using age-specific reference scores provided in the manual (mean = 100, SD = 15). The average reliability of the SON-R 2½ 7 IQ score is 0.90, range 0.86 to 0.92 for the respective age. 28 The reliability of the subtests that were used in our study is 0.73 for mosaics and 0.71 for categories. We chose a validated Dutch instrument and specifically investigated non-verbal IQ, because our sample is multi-ethnic (differences in exposure to the Dutch language in young children could be present), and bilingualism is common.
| Covariates
Potential confounders were selected based on the previous literature. 14-17,31,32 Information on gender, birth weight, and Apgar score at 5 minutes after birth were obtained from hospital records. Gestational age was obtained by foetal ultrasound examination. Maternal body mass index was determined by weight and height at the first visit. Maternal age, ethnicity, and education were assessed by questionnaires. Ethnicity was defined as Dutch, non-Dutch Western, and non-Dutch non-Western. Maternal education defined by the highest completed education was classified as "higher" (higher vocational training or higher academic education), "secondary" (more than 3 years general secondary school), and "primary" (lower vocational training or 3 years general secondary school). Maternal tobacco smoking was obtained in each trimester. On the basis of all three questionnaires, we defined the following categories: "never smoked,"
"smoked until pregnancy was known," and "continued throughout pregnancy." Maternal alcohol use was categorized into "never drank in pregnancy," "drank until pregnancy was known," "continued to drink occasionally," and "continued to drink frequently." Monthly household income at enrolment was categorized into >€ 2000 (more than modal income), €1200 to €2000, and <€1200 (below social security level).
Maternal cognitive ability was assessed during the visit to the research centre at child's age 5 to 7 years, with a computerized version of the Ravens Advanced Progressive Matrices (APM) Test, set I. 33 Set I consists of 12 items and has been shown to be a reliable and valid short form of the Raven's Progressive Matrices to asses nonverbal intelligence. 34 Maternal psychiatric symptoms were assessed at 20 weeks of pregnancy and when the child was 3 years old using the Brief Symptom Inventory (BSI), a validated self-report questionnaire. 35, 36 At 20 weeks of pregnancy the complete 53-item questionnaire was assessed, which contained the following subscales: depression, anxiety, phobic anxiety, hostility, interpersonal sensitivity, paranoid ideation, somatization, obsessive-compulsive behaviour, and psychoticism. We computed the Global Severity Index, 35 which we defined as the average item score across the two time points. Like NSAIDs, use of antidepressants (selective serotonin reuptake inhibitors) and benzodiazepines was also collected using a combination of questionnaires and pharmacy records. Further, as use of NSAIDs may co-occur with other medications, such as paracetamol (a.k.a., acetaminophen), we also collected this information from the same questionnaires (but not pharmacy records).
| Statistical analysis
We estimated the associations between prenatal NSAIDs use and the following outcomes using separate linear regression models: maternal reports of somatic complaints and attention problems at 1.5, 3, and 5 years; teaching reports of attention problems at 6 years and nonverbal intelligence at 5 years. Models were adjusted for age and gender of the child; ethnicity, age, education, and psychopathology of the mother; smoking and alcohol consumption during pregnancy; APM score of the mother; and exposure to paracetamol, antidepressants and benzodiazepines. For comparison, we also present unadjusted associations.
We used NSAIDs use before pregnancy as a negative exposure, and we used somatic complaints as a negative outcome in order to detect (residual) confounding. 20 It could be possible that maternal reports of child behaviour may be biased via the personal characteristics of the respondent 37 and to account for this potential bias, we used teacher reports of attention problems and used a testbattery as a more objective measured outcome.
The missing values on all confounders were below 20% except for the maternal cognitive ability score (22.4%). We accounted for missing information on the confounders by using the Markov Chain Monte
Carlo imputation with predictive mean matching for continuous variables. 38 Ten imputed datasets were generated using a fully conditional specified model. Analyses were performed separately on each completed dataset and thereafter combined to one pooled estimate. Children who did not have complete data on cognitive, emotional, or behavioral outcomes were more likely to have a lower birth weight and have mothers who were lower educated, younger, more likely to be non-Dutch, smoked more frequently, and had higher psychopathology symptom scores (Supplemental Table 1 ).
3 | RESULTS
| Characteristics of the study population
The maternal and child characteristics stratified by prenatal NSAID exposure (most commonly ibuprofen, naproxen, diclofenac, and aspirin) are presented in 
| Investigation of residual confounding:
Pre-pregnancy NSAID use as a "negative exposure"
Pre-pregnancy NSAID use was not strongly associated with maternally reported attention problems at ages 1.5, 3, and 5 years (Table 3) .
| Investigation of residual confounding: Somatic complaints as a "negative outcome"
Prenatal NSAIDs exposure was not strongly associated with maternal report of somatic complaints (Table 4) . For example, the adjusted mean difference in the somatic complaints score at age 3 years was 0.19 (95% CI −0.01, 0.38).
| Investigation of reporting bias: Teacher report of attention problems
In contrast to maternal report of attention problems, no strong association was seen between prenatal NSAID exposure and teacher-reported attention problems at age 6 years (mean difference in attention score: −0.24; 95% CI −1.23, 0.76). In addition, no strong association was observed between prenatal NSAID exposure and teacher-reported somatic problems at 6 years (mean difference in somatic score: −0.05; 95CI −0.17, 0.08).
Investigation of reporting bias: observed measure of non-verbal intelligence.
As shown in Table 5 
| DISCUSSION
In the present study, mothers reported that children prenatally exposed to NSAIDs had a higher risk of attention problems (particularly at younger ages). Alongside our results regarding maternal reports of somatic complaints, maternal reports of pre-pregnancy NSAIDs use, teacher reports of attention problems and somatic complaints together, and an observational measure of non-verbal intelligence, these findings altogether suggest that this apparent association can perhaps be largely explained by residual confounding by indication and measurement-related biases. Below we detail the insights gained from each of these additional analyses.
Confounding by indication is of particular concern in studying NSAID use during pregnancy, as the reasons for using these medications may affect child neurodevelopment and reporting of child neurodevelopment directly. As NSAIDs are often used to treat fever, pain, and inflammation, it could be that these underlying conditions could be risk factors for neurodevelopmental problems. 39 While we were able to adjust for a rich set of measures on maternal psychopathology and other characteristics, apparent associations may still be explained by residual confounding. We used "negative" exposures and outcomes to indirectly assess whether confounding remained.
As prenatal NSAID use and somatic complaints are likely confounded by the same sources of confounding as our primary research question, yet biologically we expect no direct effect, the fact that we found similar effect estimates (in the same direction) even after adjusting for measured confounders may suggests that the effect estimates may be biased. On the other hand, studying pre-pregnancy NSAID use and attention problems, which likewise we would biologically expect no direct effect, we did not find a robust association and the effect estimates were in the opposite direction. One possible reason for this is that the confounding structure may actually be different, as the set and severity of indications and the choice for using NSAIDs pre-pregnancy may vary substantially from what occurs during pregnancy. In other words, pre-pregnancy NSAID use may not serve as a suitable "negative" exposure after all; there is some evidence of this in the descriptive statistics in Table 1 directly affecting attention problems themselves. To assess this possibility, we considered outcomes reported by other sources, namely teacher-reported attention problems and a non-verbal cognitive functioning test performed at our research centre. We found no association between prenatal NSAIDs exposure and attention problems when the teachers reported about the child. The teachers' perspective is valuable since teachers observe child behaviour in task-oriented situations where children are required to concentrate. Moreover, teachers can easily compare a particular child's behaviour with that of a relatively large group of classmates of the same developmental level. 40 Therefore, our findings may suggest that mothers might over-report children's attention problems, and that it is important to use a multi-informant approach as information of different informants may reflect variations in children's behavior across diverse settings, and relational circumstances. [41] [42] [43] This finding is likewise corroborated by the null findings for the non-verbal intelligence score, although this score is measuring a different cognitive construct and thus can only be seen as indirect evidence of information bias.
However, there is a possibility that these associations of prenatal NSAIDs prior to and during pregnancy. Second, as is common in birth cohort studies, some selective loss to follow-up among families from low socioeconomic status and non-Western origin occurred in Generation R. 21 While our study focused on exploring confounding and information biases, future work may consider the role of selection bias due to loss to follow-up. Further, in this study we, did not examine the effects of different type of NSAIDs, dose-dependent effects, and trimester-specific effects, as the information that we collected from the questionnaires was very general. However, NSAIDS all involve COX-inhibition, followed by suppression of prostaglandin synthesis in the brain, 11 and thus type-specific effects would be unlikely. Further, somatic complaints were asked using the CBCL, this subscale specifically refers to physical problems (eg, headaches, nausea, and stomach aches) without a known medical cause, and thus we cannot exclude that part of these somatic complaints are due to underlying psychopathology. Finally, the analyses were performed using a variety of measures at different ages in slightly different samples; differences in the study populations included in each analysis or differences in their susceptibility to bias due to loss to follow up may theoretically explain some results. and thus, we need to be cautious in the interpretations of our findings. Adjusted model, covariates: age and gender of the child, ethnicity, age, education and psychopathology of the mother, smoking and alcohol consumption during pregnancy, and APM score of the mother, prenatal exposure to paracetamol, antidepressants, and benzodiazepines.
In conclusion, by controlling for several potential confounders, using outcomes measured repeatedly and across different informants, studying pre-pregnancy exposure, and using proposed negative outcomes, this study provides evidence that the observed associations between prenatal exposure to NSAIDs and child attention problems in this study and possibly previous studies likely indicate null or small (ie, near-null) causal effect.
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